Ginsenoside Rb3 strengthens the hypoglycemic effect through AMPK for inhibition of hepatic gluconeogenesis.

about

Therapeutic Potential of Ginsenosides as an Adjuvant Treatment for Diabetes.

P2860

Q55195472-B56B5E3B-F883-4BD3-9816-D2FA6EC52590

P2860

Ginsenoside Rb3 strengthens the hypoglycemic effect through AMPK for inhibition of hepatic gluconeogenesis.

Item

http://www.wikidata.org/entity/Q38752987

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Ginsenoside Rb3 strengthens th ...... on of hepatic gluconeogenesis.

@en

type

Item

label

Ginsenoside Rb3 strengthens th ...... on of hepatic gluconeogenesis.

@en

prefLabel

Ginsenoside Rb3 strengthens th ...... on of hepatic gluconeogenesis.

@en

P1476

Ginsenoside Rb3 strengthens th ...... on of hepatic gluconeogenesis.

@en

P2093

Fanli Meng

http://www.w3.org/2001/XMLSchema#string

Wei Li

http://www.w3.org/2001/XMLSchema#string

Xiaotian Su

http://www.w3.org/2001/XMLSchema#string

Yinan Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

AMP-activated protein kinase plays an important evolutionary conserved role in the regulation of glucose metabolism in fish skeletal muscle cells

PGC-1beta in the regulation of hepatic glucose and energy metabolism

The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin

The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism

Anti-diabetic effect of ginsenoside Rb(3) in alloxan-induced diabetic mice.

Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia.

The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis.

AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.

Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein.

AMPK inhibitor Compound C stimulates ceramide production and promotes Bax redistribution and apoptosis in MCF7 breast carcinoma cells.

P304

2551-2557

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2017.4280

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28565878

http://www.w3.org/2001/XMLSchema#string

P932

5443165

http://www.w3.org/2001/XMLSchema#string

Ginsenoside Rb3 strengthens the hypoglycemic effect through AMPK for inhibition of hepatic gluconeogenesis.

about

P2860

P2860

Ginsenoside Rb3 strengthens the hypoglycemic effect through AMPK for inhibition of hepatic gluconeogenesis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932